Literature DB >> 11936935

Methods to explain the clinical significance of health status measures.

Gordon H Guyatt1, David Osoba, Albert W Wu, Kathleen W Wyrwich, Geoffrey R Norman.   

Abstract

One can classify ways to establish the interpretability of quality-of-life measures as anchor based or distribution based. Anchor-based measures require an independent standard or anchor that is itself interpretable and at least moderately correlated with the instrument being explored. One can further classify anchor-based approaches into population-focused and individual-focused measures. Population-focused approaches are analogous to construct validation and rely on multiple anchors that frame an individual's response in terms of the entire population (eg, a group of patients with a score of 40 has a mortality of 20%). Anchors for population-based approaches include status on a single item, diagnosis, symptoms, disease severity, and response to treatment. Individual-focused approaches are analogous to criterion validation. These methods, which rely on a single anchor and establish a minimum important difference in change in score, require 2 steps. The first step establishes the smallest change in score that patients consider, on average, to be important (the minimum important difference). The second step estimates the proportion of patients who have achieved that minimum important difference. Anchors for the individual-focused approach include global ratings of change within patients and global ratings of differences between patients. Distribution-based methods rely on expressing an effect in terms of the underlying distribution of results. Investigators may express effects in terms of between-person standard deviation units, within-person standard deviation units, and the standard error of measurement. No single approach to interpretability is perfect. Use of multiple strategies is likely to enhance the interpretability of any particular instrument.

Entities:  

Mesh:

Year:  2002        PMID: 11936935     DOI: 10.4065/77.4.371

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  385 in total

1.  The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.

Authors:  D Feeny; C M Blanchard; J L Mahon; R Bourne; C Rorabeck; L Stitt; S Webster-Bogaert
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

2.  Using the effect size to model change in preference values from descriptive health status.

Authors:  Kristy Sanderson; Gavin Andrews; Justine Corry; Helen Lapsley
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

3.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

4.  Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.

Authors:  Jörg Witthaut; Andrew G Bushmakin; Robert A Gerber; Joseph C Cappelleri; Marie-Pierre Hellio Le Graverand-Gastineau
Journal:  Clin Drug Investig       Date:  2011-11-01       Impact factor: 2.859

5.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

6.  A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients.

Authors:  Regina Rendas-Baum; Min Yang; Francoise Cattelin; Gene V Wallenstein; John D Fisk
Journal:  Qual Life Res       Date:  2010-07-10       Impact factor: 4.147

Review 7.  Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.

Authors:  Michael Brundage; Brenda Bass; Judith Davidson; John Queenan; Andrea Bezjak; Jolie Ringash; Anna Wilkinson; Deb Feldman-Stewart
Journal:  Qual Life Res       Date:  2010-11-26       Impact factor: 4.147

8.  Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease.

Authors:  Kathleen W Wyrwich; Stacie M Metz; Kurt Kroenke; William M Tierney; Ajit N Babu; Fredric D Wolinsky
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

9.  Health-related quality of life associated with systemic corticosteroids.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Gary Globe; Brandon Sucher
Journal:  Qual Life Res       Date:  2016-10-18       Impact factor: 4.147

10.  Domain-specific transition questions demonstrated higher validity than global transition questions as anchors for clinically important improvement.

Authors:  Michael M Ward; Lori C Guthrie; Maria Alba
Journal:  J Clin Epidemiol       Date:  2015-02-11       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.